ArticlePloS one2026
Higher serum zinc micronutrient levels are associated with reduced susceptibility to Group B Streptococcus rectovaginal colonisation in pregnant women.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMaternal recto-vaginal colonisation by Group B Streptococcus (GBS) is a major risk factor for severe invasive GBS disease in newborns. Zinc is a key micronutrient known to promote defence against bacterial infections. We hypothesized that adequate zinc micronutrient levels in pregnant women would negatively affect GBS colonisation and persistence during pregnancy.
objectiveTo determine the association between serum zinc levels and risk of recto-vaginal GBS colonisation acquisition in pregnant women, as well as the potential for clearance of colonisation later in pregnancy.
methodsZinc concentrations were analysed in serum samples from women who acquired rectovaginal GBS colonisation and from women who cleared GBS colonisation between 20 weeks and 37-40 weeks of gestational age. Zinc concentration at 20-25 weeks and 37-40 weeks gestational age was measured using inductively coupled plasma mass spectrometry.
resultsHigher baseline serum zinc concentration was associated with a lower risk of new GBS acquisition [Odds ratio (OR) 0.15, p = 0.001]. Zinc geometric mean concentration was higher in women who were persistently un-colonised by GBS compared with those with a new acquisition of GBS (20.18 vs 13.68 µmol/L; p = 0.03). The lowest zinc threshold ≥15 µmol/L was associated with significantly reduced odds of new GBS acquisition (27.2% in new acquisition vs 40.5% in persistently un-colonised; OR 0.55; 95%CI 0.31-0.96; p = 0.03). An association was also evident between 15-20 umol/L serum zinc levels and greater odds of GBS colonisation clearance.
conclusionsThis study demonstrates a potential role of serum zinc nutrition in the reduced risk of recto-vaginal GBS colonisation during pregnancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.